Richard-Carpentier G. Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care. Can Hematol Today [Internet]. 2023 Mar. 1 [cited 2023 May 28];2(1):28–33. Available from: http://canadianhematologytoday.com/cht/article/view/2-1-5-richard-carpentier